000623 Jilin Aodong Pharmaceutical Group
- 15.24
- +0.16+1.06%
Jilin Aodong Pharmaceutical Group News
Listed companies that are “obsessed with stock trading”: Jilin Aodong lost more and the “top” proudly added 1 billion dollars in capital. Andeley doubles the stock price in a month while “holding” 26 A-shares
① Unlike Yunnan Baiyao's “Golden Pot Hand Wash,” Jilin Aodong announced that it plans to use no more than 1 billion yuan to invest in securities, but the total securities investment in the past 4 years has lost nearly 900 million yuan. ② Net profit of the top 100 groups surged 9 times year-on-year in the first quarter due to changes in the fair value of shares held, and Silanwei's investment loss last year was 450 million; ③ Sorting out the securities investment situation of A-share listed companies (attached table), China Communications Construction and Andeley ranked first and second in terms of the number of securities held.
Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20%
Aodong Medicine Industry Group's (SHE:000623) attributable profit fell 18% to 1.46 billion yuan in 2023 from 1.78 billion yuan in 2022, according to a Wednesday filing with the Shenzhen Stock Exchange
Jilin Aodong (000623.SZ): Net profit in 2023 fell 18.02% year-on-year, and plans to distribute 6 yuan for 10 shares
Gelonghui, April 16 | Jilin Aodong (000623.SZ) released its 2023 annual report. Operating revenue was 3.449 billion yuan, up 20.25% year on year, net profit was 1.46 billion yuan, down 18.02% year on year, after deducting non-net profit of 1,313 billion yuan, down 15.63% year on year, with basic earnings per share of 1.2971 yuan. A cash dividend of 6 yuan is distributed to all shareholders for every 10 shares.
Aodong, Jilin (000623.SZ): Produces and sells more than 200 kinds of health products such as functional health foods and dietary nutritional supplements
Gelonghui, March 27丨Jilin Aodong (000623.SZ) said on the investor interactive platform that the company produces and sells more than 200 kinds of health products such as health functional foods and dietary nutritional supplements, including ginseng mushrooms, fermented plant enzymes, immunity enhancement, eye fatigue relief, bone health, fat loss meal replacement, intestinal probiotics, vitamins and minerals.
Aodong, Jilin (000623): The main pharmaceutical industry continues to strengthen finance to empower established pharmaceutical companies to usher in new development
The “Pharmaceutical+Finance+Big Health” multi-wheel drive established pharmaceutical company has been deeply involved in the pharmaceutical industry for many years. The company takes pharmaceuticals as its core business, actively lays out the big health sector, and at the same time holds a large number of high-quality financial assets and makes extensive investments, gradually forming a”
Aodong, Jilin (000623.SZ): Produces and sells a variety of drugs in the field of proprietary Chinese medicines for kidney supplementation, mainly kidney strengthening pills used for kidney deficiency, poor qi and blood
Gelonghui, March 21丨Jilin Aodong (000623.SZ) said on the investor interactive platform that the company produces and sells a variety of drugs in the field of proprietary Chinese medicines for kidney supplementation, mainly kidney strengthening pills for kidney deficiency and poor qi and blood pressure. Tiange Kidney Supplement is suitable for nephropathy, symptoms such as fatigue, chills, cold legs, and pain in the lower back and knees. Yihechun capsules are used for various symptoms caused by renal impairment. Deer antler takes oral liquid to warm the kidneys, nourish blood, and strengthen bone marrow. It is used for stomach chills and weakness, blood deficiency and dizziness, lower back and knee weakness, and cold and blood loss. Deer Whip Rejuvenation Capsules are used for kidney weakness, insomnia, and amnesia. Five plus blood serum oral solution is used for lower back due to renal impairment
Jilin Aodong (000623.SZ) develops, produces and sells a variety of drugs in the fields of cancer, kidney disease, diabetes, cardiovascular and cerebrovascular diseases
Gelonghui, March 20 | Jilin Aodong (000623.SZ) said on the investor interactive platform that the company is developing, producing and selling a number of drugs in the fields of cancer, nephropathy, diabetes, cardiovascular and cerebrovascular diseases. Among them, injectable ribonucleic acid II is suitable for adjuvant treatment of pancreatic cancer, liver cancer, stomach cancer, lung cancer, breast cancer, soft tissue sarcoma and other cancers, and has a good effect on adjuvant treatment of hepatitis B. This product can also be used for other diseases caused by low immune function. Injectable Pingyangmycin hydrochloride treats head and neck scale cancers such as lip cancer, tongue cancer, gum cancer, and nasopharyngeal cancer. It can also be used to treat skin cancer, breast cancer,
Aodong, Jilin (000623.SZ): Proposed establishment of subsidiary Aodong Anhui Company
Gelonghui, March 18 | Jilin Aodong (000623.SZ) announced that the company held the 8th meeting of the 11th board of directors and the 7th meeting of the 11th board of supervisors to review and pass the “Bill on Foreign Investment” on March 18, 2024. According to the company's development strategy plan, the company and its holding subsidiary Jilin Aodong Yanbian Pharmaceutical Co., Ltd. (“Yanbian Pharmaceutical”) jointly invested 300 million yuan to establish a subsidiary, Aodong Pharmaceutical (Anhui) Co., Ltd. (tentative name, subject to local industrial and commercial approval, referred to as “Aodong Anhui Company”) Investment 3 million yuan, accounting for Aodong and Anhui
Aodong, Jilin (000623.SZ): The production and sale of injectable ribonucleic acid II is an immunomodulator
Gelonghui March 12 | Jilin Aodong (000623.SZ) said on the investor interactive platform that injectable ribonucleic acid II produced and sold by the company is an immunomodulator. It is suitable for adjuvant treatment of pancreatic cancer, liver cancer, stomach cancer, lung cancer, breast cancer, soft tissue sarcoma and other cancers, and has a good effect on adjuvant treatment of hepatitis B. This product can also be used for other diseases caused by low immune function. The company's chemicals include chemical injections, general chemical drugs, and chemical raw materials. Currently, the company's chemicals mainly include injectable ribonucleic acid II, injectable Pingyangmycin hydrochloride, and artificial beeswax metronidazole
Express News | Aodong, Jilin: The holding subsidiary obtained a registration certificate for the listing of traditional Chinese medicine formula granules
Jilin Aodong (000623.SZ) issued 2 billion yuan medium-term notes and was accepted for registration
Jilin Aodong (000623.SZ) issued an announcement. The company recently received an announcement from the China Interbank Market Dealers Association...
Aodong, Jilin (000623.SZ): Relying on the advantages of the pharmaceutical industry, the company produces a series of products based on the resources of the Changbaishan region, such as proprietary Chinese medicines, Chinese herbal medicines, health produ
Gelonghui, March 7 | Jilin Aodong (000623.SZ) said on the investor interactive platform that the company insists on integrating party building work into all aspects of production and operation, pushes party members and employees to compete for pioneers and set an example, and turns the Party branch into a strong grassroots battlebastion. The company actively promotes the main theme, spreads positive energy, and combines its own industrial advantages to actively fulfill its social responsibilities. Relying on the advantages of the pharmaceutical industry, the company mobilized the enthusiasm of local farmers to actively participate in the cultivation and cultivation of Chinese herbal medicines through the production of a series of products, such as proprietary Chinese medicines, Chinese herbal medicine tablets, and health products, mainly from the Changbaishan region, and supported and encouraged plum
Aodong, Jilin (000623.SZ): Currently, there are 616 drug production approval numbers. A total of 206 products have been included in the national medical insurance catalogue, and a total of 91 products have entered the national essential drug catalogue
Gelonghui, March 7 | Jilin Aodong (000623.SZ) said on the investor interactive platform that the company currently has 616 drug production approval numbers, a total of 206 products have been included in the national medical insurance catalogue, and a total of 91 products have entered the national essential drugs catalogue. The pediatric drug catalogue categories include Pediatric Chai Gui Antipyretic Oral Liquid and Sports Digestive Oral Liquid. As a national exclusive patented product (Patent No.: ZL200410010761.1), Pediatric Chai Gui Antipyretic Oral Liquid has developed into a core variety after years of cultivation. The company insists on continuing to deepen the field of pediatrics and increase investment in scientific research and academics
Aodong, Jilin (000623.SZ): Pibacilli capsules and pibasilil APIs approved
Zhitong Finance App News, Jilin Aodong (000623.SZ) issued an announcement. Recently, the company's holding subsidiary, Jilin Aodong Taonan Pharmaceutical Co., Ltd. (“Taonan Pharmaceutical”), received the specifications of pibesilil capsules issued by the State Drug Administration: 100 mg, 75 mg, 125 mg, three “Drug Registration Certificates” and pibesilil's “Notice of Approval of the Marketing Application for Chemical Ingredients”. The approval of pibesilil capsules and pibesilil APIs has improved the company's product structure, further enriched the company's range of APIs and capsule formulations, enhanced the company's core competitiveness, and further strengthened the company
Aodong, Jilin (000623.SZ): Taonan Pharmaceutical obtained a drug registration certificate and a notice of approval for the marketing application of chemical raw materials
Gelonghui, March 1, 丨 Jilin Aodong (000623.SZ) announced that recently, Jilin Aodong Taonan Pharmaceutical Co., Ltd. (“Taonan Pharmaceutical”), a holding subsidiary of Jilin Aodong Pharmaceutical Group Co., Ltd., received the specifications of pibesilide capsules issued by the State Drug Administration: 100 mg, 75 mg, 125 mg, and the “Notice of Approval of Application for the Marketing of Chemical Ingredients”.
Aodong, Jilin (000623.SZ): The company has a variety of drugs used to prevent influenza virus, treat influenza, and reduce fever
Gelonghui, Feb. 27丨Jilin Aodong (000623.SZ) said on the investor interactive platform that the company has a variety of drugs used to prevent the influenza virus, treat influenza, and reduce fever. “Chai Gui Antipyretic Oral Solution for Children” is a traditional Chinese medicine for fever relief. It has the function of relieving sweating and relieving fever. Used for external fever in children. Symptoms: fever, headache, runny nose, thirst, red throat, yellow, dry stools. Currently, “Pediatric Chai Gui Antipyretic Oral Solution” has been recommended for use in multiple clinical guidelines. In clinical applications, it also has specific symptoms such as “high cure rate, low recurrence rate, short treatment cycle, stable and no rebound in fever”
Aodong, Jilin (000623.SZ): CXO and CRO related businesses have not been deployed
Gelonghui, Feb. 26 | Aodong, Jilin (000623.SZ) said on the investor interactive platform that the company is a pharmaceutical manufacturer, mainly engaged in R&D, manufacturing and sales of traditional Chinese medicines and chemicals. Currently, the company's business scope covers proprietary Chinese medicines, traditional Chinese medicine formula granules, Chinese medicine tablets, chemicals, etc., while actively laying out health food, food, breeding, planting and other fields, gradually forming a “pharmaceutical+finance+big health” multi-wheel drive development model. The company has no CXO and CRO related businesses.
Aodong, Jilin (000623.SZ): By the end of 2023, the company had registered 400 varieties of traditional Chinese medicine formula granules
Gelonghui Feb. 21丨Jilin Aodong (000623.SZ) held a roadshow on February 21, 2024 to discuss “How is the filing and collection of Chinese medicine formula granules in the company?” The company replied that by the end of 2023, the company had registered 400 varieties of traditional Chinese medicine formula granules for marketing. Traditional Chinese medicine formula granules are the company's development business. The company has established complete, comprehensive and strict product standards, and achieved quality control throughout the process of formula granules from medicinal materials to finished products. It has shown significant advantages in the supply chain, quality assurance, and service system. The number and production capacity of traditional Chinese medicine formula granules can fully meet the requirements
Aodong, Jilin (000623.SZ): At present, Anshen Brain Tonic has developed into a core variety with annual sales revenue of over 600 million yuan
Gelonghui Feb. 21丨Jilin Aodong (000623.SZ) held a roadshow on February 21, 2024 to discuss “Are there any plans to increase the price of brain fluid to calm the mind?” The company replied that at present, Brain Relief has developed into a core variety with annual sales revenue of over 600 million yuan. In the future, the company will comprehensively consider whether to adjust prices based on market conditions, sales pricing strategies, and market consumer acceptance.
Liaoning Chengda (600739.SH): Jilin Aodong increased its A-share holdings by 9.551 million
Gelonghui, January 31, 丨 Liaoning Chengda (600739.SH) announced that from November 17, 2023 to January 31, 2024, Jilin Aodong used its own funds to increase its holdings of the company's A-share common shares by 9.5,100 through centralized bidding transactions at the Shanghai Stock Exchange. The current plan to increase holdings has not yet been implemented.
Analysis
Price Target
No Data
